Table 5.
Antimicrobial therapy, microbiology specimens and organisms identified
| Antimicrobial Prescription | 307/338 (90.8%) |
| Piperacillin/tazobactam | 133 (39.3%) |
| Amoxicillin/clavulanate | 65 (19.2%) |
| Meropenem | 23 (6.8%) |
| Metronidazole | 15 (4.4%) |
| Cephalosporin | 14 (4.1%) |
| Ciprofloxacin | 13 (3.8%) |
| Gentamycin | 10 (3.0%) |
| Ciprofloxacin and metronidazole | 11 (3.3%) |
| Cephalosporin and metronidazole | 11 (3.3%) |
| Amoxicillin/clavulanate and gentamycin | 6 (1.8%) |
| Amoxicillin/clavulanate and metronidazole | 6 (1.8%) |
| Did not receive antimicrobial treatment | 31/338 (9.2%) |
| Blood and bile cultures | 154/338 (45.5%) |
| Blood cultures | |
| Yes | 47 (30.5%) |
| No | 107 (69.5%) |
| Bile cultures | |
| Yes | 35 (22.7%) |
| No | 119 (77.3%) |
| Organism identified on culture | 40 blood, 52 bile |
| E. coli | 11 blood, 20 bile |
| Klebsiella spp. | 2 blood, 4 bile |
| Staphylococcus spp. | 3 blood, 3 bile |
| Streptococcus spp. | 0 blood, 4 bile |
| Enterococcus spp. | 0 blood, 4 bile |
| Pseudomonas spp. | 1 blood, 1 bile |
| Other organisms | 2 blood, 6 bile |
| Polymicrobial | 1 blood, 10 bile |
| No growth | 61 blood, 69 bile |